DSIP Research for Insomnia
An evidence-based overview of research examining DSIP in the context of insomnia. This page synthesizes findings from peer-reviewed literature.
Research Summary
Swiss researchers in the 1980s conducted multiple human studies on DSIP for insomnia. Schneider-Helmert and colleagues found that DSIP acted as a sleep 'normalizer' rather than a sedative, with effects more pronounced in sleep-disturbed individuals. A 6-month follow-up study showed sustained benefits in some patients. However, high inter-individual variability was noted.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Insomnia
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. DSIP may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.